We are live on
!
Find out more
SLG
Stanley-Laman Group Portfolio holdings
AUM
$814M
1-Year Est. Return
40.24%
This Fund
S&P 500
This Quarter
Est. Return
+4.51%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$369M
AUM Growth
-$418K
(-0.11%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-3.37%
Top 10 Holdings %
Top 10 Hldgs %
23.09%
Holding
244
New
26
Increased
87
Reduced
73
Closed
45
Top Buys
| 1 |
Altria Group
MO
|
+$3.02M |
| 2 |
Pfizer
PFE
|
+$3M |
| 3 |
CVS Health
CVS
|
+$2.72M |
| 4 |
Kraft Heinz
KHC
|
+$2.68M |
| 5 |
Exelon
EXC
|
+$2.67M |
Top Sells
| 1 |
MON
Monsanto Co
MON
|
+$3.8M |
| 2 |
Cedar Fair
FUN
|
+$2.55M |
| 3 |
AstraZeneca
AZN
|
+$2.41M |
| 4 |
GSK
GSK
|
+$2.38M |
| 5 |
PPL
PPL Corp
PPL
|
+$2.23M |
Sector Composition
| 1 | Technology | 14.63% |
| 2 | Healthcare | 14.59% |
| 3 | Consumer Staples | 11.98% |
| 4 | Industrials | 10.74% |
| 5 | Utilities | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Palo Alto Networks
PANW
$292B
| $16.5M | 4.48% |
740,988
-45,816
| -6% | -$926K |
|
2
MDU Resources
MDU
$4.42B
| $13M | 3.54% |
1,309,062
-9,781
| -0.7% | -$100K |
|
3
Ingredion
INGR
$6.47B
| $13M | 3.53% |
109,167
-2,774
| -2% | -$329K |
|
4
Walt Disney
DIS
$170B
| $8M | 2.17% |
75,261
+3,273
| +5% | +$358K |
|
|
TIF
5
DELISTED
Tiffany & Co.
TIF
| $6.81M | 1.85% |
72,500
-2,500
| -3% | -$229K |
|
6
Qualys
QLYS
$5.61B
| $5.82M | 1.58% |
142,757
-6,065
| -4% | -$244K |
|
|
ATVI
7
DELISTED
Activision Blizzard
ATVI
| $5.63M | 1.53% |
97,714
-2,171
| -2% | -$120K |
|
8
Trimble
TRMB
$12.3B
| $5.5M | 1.49% |
154,102
-6,094
| -4% | -$212K |
|
9
PayPal
PYPL
$49.9B
| $5.42M | 1.47% |
100,926
-5,944
| -6% | -$292K |
|
10
Darling Ingredients
DAR
$10B
| $5.37M | 1.46% |
340,824
+8,038
| +2% | +$124K |
|
11
Supernus Pharmaceuticals
SUPN
$2.79B
| $5.34M | 1.45% |
124,000
-3,481
| -3% | -$124K |
|
|
KSU
12
DELISTED
Kansas City Southern
KSU
| $5.24M | 1.42% |
50,106
-2,927
| -6% | -$274K |
|
13
Curtiss-Wright
CW
$26.1B
| $5.16M | 1.4% |
56,197
+19,922
| +55% | +$1.8M |
|
14
FMC
FMC
$1.4B
| $5.16M | 1.4% |
81,417
-7,310
| -8% | -$471K |
|
|
GRA
15
DELISTED
W.R. Grace & Co.
GRA
| $5.11M | 1.39% |
70,929
-2,209
| -3% | -$155K |
|
|
WBMD
16
DELISTED
WebMD Health Corp.
WBMD
| $4.85M | 1.32% |
82,725
-2,730
| -3% | -$152K |
|
|
HOLX
17
DELISTED
Hologic
HOLX
| $4.8M | 1.3% |
105,809
+1,950
| +2% | +$86.1K |
|
18
Thermo Fisher Scientific
TMO
$198B
| $4.79M | 1.3% |
27,455
+830
| +3% | +$139K |
|
19
Ball Corp
BALL
$16.7B
| $4.7M | 1.27% |
111,328
-14,166
| -11% | -$560K |
|
20
Labcorp
LH
$23.2B
| $4.39M | 1.19% |
33,184
+1,184
| +4% | +$145K |
|
21
Fortune Brands Innovations
FBIN
$6.14B
| $4.34M | 1.18% |
77,765
-616
| -0.8% | -$33.4K |
|
22
Carlisle Companies
CSL
$14B
| $4.22M | 1.15% |
44,288
+869
| +2% | +$87.8K |
|
|
BERY
23
DELISTED
Berry Global Group, Inc.
BERY
| $4.13M | 1.12% |
78,995
+945
| +1% | +$47.3K |
|
24
Avient
AVNT
$3.39B
| $4.09M | 1.11% |
105,533
-4,982
| -5% | -$185K |
|
|
TEN
25
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $4.08M | 1.11% |
70,563
+1,688
| +2% | +$97.5K |
|
Similar funds
VFG
KCP
AR
CICI
TFM
UAG
PS
BC
Stanley-Laman Group's Q2 2017 Portfolio in Review
As of Q2 2017, Stanley-Laman Group held 244 positions worth $369M, down 0.11% from $369M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Stanley-Laman Group withdrew a net $12.4M in Q2 2017, closing 45 positions and reducing 73 holdings. Its most notable exit was Cedar Fair, an estimated $2.55M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Stanley-Laman Group opened a new position in Altria Group worth $3.07M.
- Stanley-Laman Group's largest Q2 2017 buy was Altria Group: 41,225 shares worth $3.07M.
- Stanley-Laman Group added most to Pfizer in Q2 2017, an estimated $3M increase.
- Stanley-Laman Group's biggest Q2 2017 reduction was Monsanto Co, cutting an estimated $3.8M.
- Stanley-Laman Group fully exited Cedar Fair in Q2 2017, selling an estimated $2.55M.
- Stanley-Laman Group's ten largest holdings make up 23% of its $369M portfolio in Q2 2017.
- Stanley-Laman Group opened 26 new positions and closed 45 in Q2 2017.
- Stanley-Laman Group's portfolio value fell 0.11% quarter-over-quarter to $369M.
Based on Stanley-Laman Group's 13F filing for Q2 2017, filed 7 Aug 2017.